PMV Pharmaceuticals Inc.

NASDAQ: PMVP · Real-Time Price · USD
1.50
-0.05 (-3.23%)
At close: Aug 15, 2025, 3:59 PM
1.49
-1.00%
After-hours: Aug 15, 2025, 05:54 PM EDT

PMV Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-21.21M -17.44M -23M -19.23M -1.21M -15.27M -15.76M -16.64M -17.44M -19.13M -19.34M -18.23M -17.31M -18.43M -18.36M -15.01M -12.87M -11.6M
Depreciation & Amortization
32K 37K 39K 371K 372K 362K 359K 358K 369K 171K 75K 74K 82K 84K 77K 80K 71K 79K
Stock-Based Compensation
1.67M 1.51M 1.27M 2.22M 2.77M 2.61M 2.97M 3.32M 3.15M 2.93M 3.05M 2.45M 2.52M 2.18M 1.77M 1.8M 1.15M 627K
Other Working Capital
n/a 1.45M -3.07M 6.69M -5.73M 210K 755K 1.05M 55K 1.52M 2.6M -3.1M 2.53M -2.2M 3.49M 1.44M 816K -1.82M
Other Non-Cash Items
1.21M -840K 3.58M -4.43M -1.65M 4.01M -4.76M -95K -98K -802K -447K -156K 81K 137K 328K 313K 479K 167K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 2.8M -1.84M -957K n/a n/a n/a n/a n/a 91K 127K n/a n/a
Change in Working Capital
n/a -1.53M 1.45M 4.22M -2.05M -2.17M 2.31M -764K 2.07M 1.81M 1.34M -896K 950K -1.96M 4.07M 297K 1.93M -2.17M
Operating Cash Flow
-18.3M -18.27M -16.66M -16.84M -1.6M -16.18M -12.09M -15.66M -12.9M -15.01M -15.32M -16.76M -13.68M -18M -12.03M -12.4M -9.24M -12.9M
Capital Expenditures
-11K -4K -56K -1K -4K -594K -197K -44K -565K -156K -1.64M -2.05M -3.5M -796K -262K -501K -466K -120K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -47.19K 33.59K 63.4K -49.8K -24.86K -31.56K 11.78K n/a 2.74M n/a n/a n/a
Purchase of Investments
-30.96M -15.73M -37.51M -39.4M -40.88M -30.49M -33.39M -57.59M -106.05M -23.5M -34.69M -45.29M -55.52M -93.7M -21.68M -49.94M -45.45M -139.78M
Sales Maturities Of Investments
41.93M 44.45M 45.09M 56.49M 43.21M 57.25M 31M 24M 42.65M 73.3M 59.55M 76.85M 43.74M 55.68M 29.5M 49.75M 35.36M n/a
Other Investing Acitivies
30K n/a 222K 29K 2.33M 26.76M 47.19K -33.59K -63.4K 49.8K 24.86K 31.56K -11.78K -38.03M -2.74M -192K -10.09M -139.78M
Investing Cash Flow
10.99M 28.71M 7.74M 17.12M 2.32M 26.17M -2.59M -33.64M -63.96M 49.65M 23.22M 29.51M -15.28M -38.83M 7.56M -693K -10.55M -139.9M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-10K 10K 172K -141K 141K n/a 288K 51K 2.13M 12K 548K 6K 276K 128K 295K 309K 1.26M 162K
Financial Cash Flow
103K 10K 172K n/a 141K n/a 288K 33.15M 2.13M 12K 548K 6K 276K 128K 295K 309K 1.26M 162K
Net Cash Flow
-7.21M 10.46M -8.76M 284K 872K 9.95M -14.35M -16.15M -74.73M 34.65M 8.45M 12.76M -28.68M -56.7M -4.17M -12.78M -18.54M -152.64M
Free Cash Flow
-18.31M -18.27M -16.72M -16.84M -1.6M -16.78M -12.28M -15.7M -13.47M -15.17M -16.96M -18.81M -17.18M -18.79M -12.29M -12.9M -9.71M -13.02M